We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

112 hedge funds and large institutions have $111M invested in MaxCyte in 2025 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 41 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.33% less ownership

Funds ownership: 67.06% → 65.73% (-1.3%)

7% less funds holding

Funds holding: 120 → 112 (-8)

22% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 41

29% less capital invested

Capital invested by funds: $156M → $111M (-$45M)

29% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 24

Holders
112
Holders Change
-8
Holders Change %
-6.67%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
17
Increased
32
Reduced
41
Closed
24
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$3.66M
2
MFS
Mirabella Financial Services
United Kingdom
+$2.78M
3
WIC
Willis Investment Counsel
Georgia
+$838K
4
SCM
Stonepine Capital Management
Oregon
+$798K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$657K

Top Sellers

Rank Fund Capital Flow
1
Axa
Axa
France
-$4.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.13M
3
Chevy Chase Trust
Chevy Chase Trust
Maryland
-$2.54M
4
SAM
Silvercrest Asset Management
New York
-$2.34M
5
RA
Royce & Associates
New York
-$1.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
AMH
26
Apollo Management Holdings
New York
$487K – – –
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$470K +$480K +276,087 +1,281%
Barclays
28
Barclays
United Kingdom
$461K -$51.4K -29,590 -9%
Chevy Chase Trust
29
Chevy Chase Trust
Maryland
$417K -$2.54M -1,459,546 -85%
HSBC Holdings
30
HSBC Holdings
United Kingdom
$408K -$8.37K -4,814 -2%
Charles Schwab
31
Charles Schwab
California
$399K -$76.9K -44,238 -15%
RG
32
Rathbones Group
United Kingdom
$369K -$6.23K -3,583 -2%
LM
33
Luminus Management
Texas
$356K +$391K +225,000 New
N
34
Nuveen
North Carolina
$343K – – –
American Century Companies
35
American Century Companies
Missouri
$329K +$19.9K +11,450 +6%
BCM
36
Bridgeway Capital Management
Texas
$286K +$97K +55,800 +45%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$235K -$3.2K -1,843 -1%
Fidelity Investments
38
Fidelity Investments
Massachusetts
$212K -$3.13M -1,801,245 -93%
SO
39
STRS Ohio
Ohio
$205K – – –
BIG
40
Brooklyn Investment Group
New York
$179K -$13K -7,500 -8%
Millennium Management
41
Millennium Management
New York
$173K -$93.6K -53,838 -33%
AllianceBernstein
42
AllianceBernstein
Tennessee
$158K – – –
US Bancorp
43
US Bancorp
Minnesota
$137K – – –
Deutsche Bank
44
Deutsche Bank
Germany
$132K +$25.5K +14,677 +21%
ACH
45
ArrowMark Colorado Holdings
Colorado
$132K – – –
Wells Fargo
46
Wells Fargo
California
$123K +$22K +12,642 +19%
Bank of America
47
Bank of America
North Carolina
$114K -$22K -12,672 -15%
Invesco
48
Invesco
Georgia
$113K +$36.6K +21,049 +42%
JP Morgan Chase
49
JP Morgan Chase
New York
$102K -$32.4K -18,622 -22%
Los Angeles Capital Management
50
Los Angeles Capital Management
California
$100K – – –
1
2
3 4 5

MXCT Hedge Fund Activity: Q3 2025 in Review

112 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2025, worth a combined $111M — down 29% from $156M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of MXCT and 17 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 32 added.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $3.66M. The largest seller was Axa, exiting entirely with an estimated $4.8M sold.

  • 112 institutional investors held MaxCyte (MXCT) as of Q3 2025, down from 120 in Q2 2025.
  • Funds reported $111M of MaxCyte stock for Q3 2025, down 29% quarter-over-quarter.
  • 17 funds opened new MaxCyte positions in Q3 2025 and 24 closed out, a net change of -7 holders.
  • The largest MaxCyte buyer in Q3 2025 was Kennedy Capital Management, an estimated $3.66M added.
  • The largest MaxCyte seller in Q3 2025 was Axa, an estimated $4.8M sold.

Based on aggregated 13F filings for Q3 2025.